Current literature says 7 to 25% capsular contracture recurrence — but that depends entirely on how it's treated. With biofilm rule-out, complete capsulectomy, pulse lavage, new instruments, a new implant, and scaffolding, I keep mine well below that. And I'm a PI on the STANCE trial if you want to be part of the science.
A great question came in: "If I fix a capsular contracture, how likely is it to come back?" And the honest answer depends almost entirely on how it gets treated.
This is something I'm genuinely passionate about. I'm currently a principal investigator on an FDA trial for contracture treatment (the STANCE trial, available on clinicaltrials.gov) — so if you have a contracture and you're interested, feel free to DM me.
Here's the full breakdown of why recurrence rates vary so much, what I do to keep mine low, and the things I'd skip.
Old data on capsular contracture treatment was bleak — recurrence rates after surgical correction were genuinely very high.
Current literature has improved dramatically:
The reason recurrence rates have come down — and why my numbers are lower than published averages — is that we've figured out a lot more about what causes recurrence and are now using a stack of techniques designed to prevent it.
When I take a patient back to the OR for a capsular contracture revision, here's the full protocol:
Biofilm — a low-grade, sub-clinical bacterial colonization of the implant — is a major contributor to capsular contracture. It often doesn't grow on standard cultures because the bacteria are protected within the biofilm matrix.
To get around this:
Because PCR results don't come back immediately, I start patients on antibiotics intraoperatively that cover the most common pathogens I see causing contracture in my practice. Once the PCR results come back, we tailor the antibiotics to whatever the test identified (or de-escalate if it's negative).
This is where there's some legitimate controversy in the field. Some surgeons cite literature showing that neopocket creation, total capsulectomy, and anterior capsulectomy all have similar recurrence rates.
My honest take: the recurrence rates in those studies are higher than what I see in my practice. I take the entire capsule out, always. A few reasons:
That said, this is one of those areas where reasonable surgeons can disagree. The literature does show that other approaches can work — but in my hands, complete capsulectomy gives me the lowest recurrence rate.
After the capsule is out, I do a pulse lavage — essentially a medical power wash of the surgical pocket. This further reduces bacterial count and helps clear any residual biofilm we couldn't see.
This is a small step that matters a lot:
The old implant is never reused:
I'm a strong believer in scaffolding — either dermal matrix (like AlloDerm or Strattice) or dissolvable mesh (like TIGR or Galaflex).
You'll occasionally see people say that contractures don't need to be treated — that they'll just come back, so why bother?
I disagree, strongly. Here's why.
A contracture isn't just a cosmetic issue. It's often:
You deserve soft, non-painful breasts. You deserve to feel comfortable in your own body. This is fixable, and I hate when patients are told to just live with it.
Chronic contractures have been associated with a rare cancer called BIA-SCC (breast implant-associated squamous cell carcinoma). This is far less common than BIA-ALCL, but it's real.
The risk is small. But for that reason as well, I'd rather not let chronic contracture sit indefinitely if it can be fixed.
This part is important and underappreciated. Even with cosmetically-placed implants, insurance will often cover a portion of contracture surgery:
That can meaningfully reduce your out-of-pocket cost. Ask your plastic surgeon's office about insurance options before assuming this is fully cash-pay.
A few therapies that get marketed for contracture treatment that I personally don't use in my practice:
This is an external ultrasound treatment marketed for capsular contracture.
These are oral medications sometimes recommended for contracture prevention.
If you have a current capsular contracture and you're thinking about treatment, there's an FDA trial I'm a principal investigator on called the STANCE trial.
If you're going in for a contracture revision, here are specific questions worth asking:
Surgeons with low recurrence rates will be specific and confident in their answers. Surgeons with high recurrence rates often skip several of these steps.
Capsular contracture recurrence rates depend almost entirely on how the contracture is treated. Current literature suggests 7–25% recurrence, but with a comprehensive approach — biofilm workup, complete capsulectomy, pulse lavage, instrument change, new implant, and liberal scaffolding — those numbers can come down significantly.
You deserve to have a contracture treated. The "just leave it alone" advice is outdated and ignores both your daily comfort and the small but real cancer risk of leaving chronic contracture in place.
And if you're interested in being part of the science on this — DM me about the STANCE trial.